Correlation Between Rallybio Corp and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Rallybio Corp and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rallybio Corp and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rallybio Corp and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Rallybio Corp and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rallybio Corp with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rallybio Corp and Mineralys Therapeutics,.
Diversification Opportunities for Rallybio Corp and Mineralys Therapeutics,
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Rallybio and Mineralys is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Rallybio Corp and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Rallybio Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rallybio Corp are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Rallybio Corp i.e., Rallybio Corp and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Rallybio Corp and Mineralys Therapeutics,
Given the investment horizon of 90 days Rallybio Corp is expected to generate 0.53 times more return on investment than Mineralys Therapeutics,. However, Rallybio Corp is 1.9 times less risky than Mineralys Therapeutics,. It trades about 0.03 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.05 per unit of risk. If you would invest 104.00 in Rallybio Corp on August 28, 2024 and sell it today you would earn a total of 1.00 from holding Rallybio Corp or generate 0.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rallybio Corp vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Rallybio Corp |
| Mineralys Therapeutics, |
Rallybio Corp and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rallybio Corp and Mineralys Therapeutics,
The main advantage of trading using opposite Rallybio Corp and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rallybio Corp position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Rallybio Corp vs. Century Therapeutics | Rallybio Corp vs. Edgewise Therapeutics | Rallybio Corp vs. C4 Therapeutics | Rallybio Corp vs. Mineralys Therapeutics, Common |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |